Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine in Lung Resection Surgery
NCT03905837Phase 4Completed
- Start
- Jan 2019
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative complications (3 arms). Primary endpoint: Postoperative complications at 30 days. Started Jan 2019; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative complications
Beyond the preview
Go deeper on NCT03905837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03905837.